These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6201959)

  • 41. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
    Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
    Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-globulins in the surveillance of colorectal cancer.
    Cooper EH; Turner R; Geekie A; Neville AM; Goligher JC; Graham NG; Giles GR; Hall R; Macadam WA
    Biomedicine; 1976 Jun; 24(3):171-8. PubMed ID: 62590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer.
    Anthony T; Simmang C; Hyman N; Buie D; Kim D; Cataldo P; Orsay C; Church J; Otchy D; Cohen J; Perry WB; Dunn G; Rafferty J; Ellis CN; Rakinic J; Fleshner P; Stahl T; Gregorcyk S; Ternent C; Kilkenny JW; Whiteford M;
    Dis Colon Rectum; 2004 Jun; 47(6):807-17. PubMed ID: 15108028
    [No Abstract]   [Full Text] [Related]  

  • 44. Value of plasma alpha-1-acid glycoprotein assay in the detection of human colorectal cancer: comparison with carcinoembryonic antigen.
    Chu CY; Lai LT; Pokala HP
    J Natl Cancer Inst; 1982 Jan; 68(1):75-9. PubMed ID: 7033631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Value of carcinoembryonic antigen (CEA) in the diagnosis and postoperative monitoring of patients with colorectal cancer].
    Catania G; Basile F; Cardì F; Azzarello G; Mazzarino C; Campo M; Giovinetto A
    Minerva Chir; 1981 May; 36(9):569-80. PubMed ID: 6789243
    [No Abstract]   [Full Text] [Related]  

  • 46. Biochemical and immunologic diagnosis of cancer. Colorectal cancer.
    von Kleist S
    Tumour Biol; 1987; 8(2-3):78-83. PubMed ID: 3329404
    [No Abstract]   [Full Text] [Related]  

  • 47. Postoperative monitoring of CEA in the prediction of surgical outcome in colorectal cancer.
    Smith AN; Gordon A; Browning GC; Williams AE; Sturgeon CM; Seth J
    J R Coll Surg Edinb; 1985 Oct; 30(5):294-8. PubMed ID: 4078776
    [No Abstract]   [Full Text] [Related]  

  • 48. [The significance of the carcinoembryonic antigen in colorectal carcinoma].
    Fischer J; Faltýnek L; Fischerová E; Rozprímová L; Bachleda P
    Cesk Gastroenterol Vyz; 1983 Dec; 37(8):485-94. PubMed ID: 6652727
    [No Abstract]   [Full Text] [Related]  

  • 49. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
    von Kleist S
    Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of plasma CEA assay in the patients with colorectal carcinoma.
    Tamura T; Kunitomo K; Korematsu H; Ando M; Fujita H; Iwasaka N; Yoshikawa H; Kuwashima T; Komi N
    Tokushima J Exp Med; 1982 Jun; 29(1-2):71-6. PubMed ID: 7147244
    [No Abstract]   [Full Text] [Related]  

  • 51. [Imaging of the recurrence of colorectal cancer].
    Chossiére L; Rahmouni A; Le Bourgeois JP
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):79-80. PubMed ID: 8737501
    [No Abstract]   [Full Text] [Related]  

  • 52. [Follow-up procedure for colorectal cancer (author's transl)].
    Metzger U; Schneider K; Buchmann P; Largiadèr F
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):327-31. PubMed ID: 7071049
    [No Abstract]   [Full Text] [Related]  

  • 53. [Leukocyte adherence inhibition test and carcinoembryonic antigen in colorectal carcinoma].
    Shani A; Weissman Z; Cohen Z; Amruch D; Cohen O; Nissim F; Shindel A; Sela A; Rosen A; Modan M; Bentwich Z
    Harefuah; 1981 Nov; 101(10):241-3. PubMed ID: 6749609
    [No Abstract]   [Full Text] [Related]  

  • 54. Carcinoembryonic antigen II.
    Taylor DG
    J Tenn Med Assoc; 1974 Apr; 67(4):313. PubMed ID: 4822906
    [No Abstract]   [Full Text] [Related]  

  • 55. [Use of the carcinoembryonic antigen in the diagnosis of colorectal cancer].
    Simici P; Popa F; Păunescu V; Herşcovici H
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(1):57-64. PubMed ID: 3158035
    [No Abstract]   [Full Text] [Related]  

  • 56. [The use of CEA radioimmunoassay for the detection of recurrence of carcinoma of the large bowel (author's transl)].
    Jaquet H; Mach JP; Pettavel J
    Langenbecks Arch Chir; 1976 Nov; 342():243-9. PubMed ID: 994637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postoperative screening of patients with carcinoma of the colon.
    Beart RW; Metzger PP; O'Connell MJ; Schutt AJ
    Dis Colon Rectum; 1981; 24(8):585-8. PubMed ID: 7318620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Radioimmunologic determination of beta 2-microglobulin and carcinoembryonic antigen in the diagnosis of recurrences of rectal cancer].
    Ozhiganov EL; Kuznetsova LF
    Med Radiol (Mosk); 1986 Apr; 31(4):23-5. PubMed ID: 3515109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Value of diagnostic procedures and after care problems in local and regional recurrence of tumors of the gastrointestinal system].
    Eigler FW; Gross E; Heckemann R
    Chirurg; 1985 Aug; 56(8):485-91. PubMed ID: 3899545
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical significance of routine serum CEA determination in postoperative control in colorectal cancer].
    Pompecki R; Winkler R
    Med Welt; 1980 Dec; 31(49):1780-3. PubMed ID: 7207116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.